Overview and recent advances in the treatment of neuroblastoma
SB Whittle, V Smith, E Doherty, S Zhao… - Expert review of …, 2017 - Taylor & Francis
Introduction: Children with neuroblastoma have widely divergent outcomes, ranging from
cure in> 90% of patients with low risk disease to< 50% for those with high risk disease …
cure in> 90% of patients with low risk disease to< 50% for those with high risk disease …
Novel therapies for relapsed and refractory neuroblastoma
PE Zage - Children, 2018 - mdpi.com
While recent increases in our understanding of the biology of neuroblastoma have allowed
for more precise risk stratification and improved outcomes for many patients, children with …
for more precise risk stratification and improved outcomes for many patients, children with …
Ifosfamide, carboplatin, and etoposide for neuroblastoma: a high‐dose salvage regimen and review of the literature
BH Kushner, S Modak, K Kramer, EM Basu… - Cancer, 2013 - Wiley Online Library
BACKGROUND: The authors report a retrospective analysis of high‐dose ifosfamide,
carboplatin, and etoposide (HD‐ICE) for patients with refractory or relapsed neuroblastoma …
carboplatin, and etoposide (HD‐ICE) for patients with refractory or relapsed neuroblastoma …